Skip to main content
  • MitraClip Implantation in Younger Patients and Pediatric Populations: 19 Year-Old Patient with Multiple Comorbidities and a Prior Mitral Valve Annuloplasty

    Highlights

    • Percutaneous mitral valve repair can be considered safe and efficacious for young patients who have high surgical risk and cannot tolerate surgery.
    • Clinical outcomes of this procedure can be better than echocardiographic outcomes.
    • Patients with chronic kidney failure can be treated cautiously with this method.

    Abstract

    MitraClip is an effective treatment method for severe mitral regurgitation in high-risk populations in terms of reducing morbidity and frequency of hospitalizations. Efficacy and safety of MitraClip device in elderly population have been established, yet there are only 2 case reports of MitraClip implantation in the younger patients, who generally tend to have less surgical risk (Gorenflo et al.; Joffe et al., 2016). We describe a 19-year-old patient with severe mitral regurgitation with prior mitral valve annuloplasty and received MitraClip implantation due to high-surgical risk.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details